World's Best Scientists 2026 revealed!
Christie M. Ballantyne

Christie M. Ballantyne

Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
168
Citations
125800
World Ranking
941
National Ranking
557

Medicine

D-Index
172
Citations
131565
World Ranking
488
National Ranking
289

Christie M. Ballantyne publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christie M. Ballantyne sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,375 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Christie M. Ballantyne D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christie M. Ballantyne sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 172 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award
  • 2013 - Distinguished Fellowship Award, American College of Cardiology (ACC)
  • 2004 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Christie M. Ballantyne is affiliated with Baylor College of Medicine in the United States. Their academic work primarily spans the field of Medicine, with a focus on Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism, Economics and Econometrics, and Genetics. Their research emphasizes aspects of cardiovascular health, lipoproteins, lipid metabolism, and associated metabolic conditions.

The main topics covered in Christie Ballantyne's publications include:

  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Systems, Economic Evaluations, Quality of Life
  • Lipid metabolism and disorders
  • Cancer, Lipids, and Metabolism
  • Cardiovascular Health and Risk Factors
  • Cardiovascular Function and Risk Factors

Christie Ballantyne has contributed numerous articles to respected scientific venues. The most frequent publication outlets for their work are:

  • Circulation
  • Journal of the American College of Cardiology
  • UNC Libraries
  • Journal of clinical lipidology
  • Journal of the American Heart Association

Among recent significant papers where Christie Ballantyne appears as an author or coauthor are:

  • "Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk" (2020, JAMA)
  • "Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality" (2023, New England Journal of Medicine)
  • "The ARIC (Atherosclerosis Risk In Communities) Study" (2021, Journal of the American College of Cardiology)
  • "2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk" (2022, Journal of the American College of Cardiology)
  • "Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study" (2021, European Heart Journal)

Frequent collaborators in Christie Ballantyne's research include:

  • Ron C. Hoogeveen
  • Salim S. Virani
  • Vijay Nambi
  • Josef Coresh
  • Kunihiro Matsushita

Throughout their career, Christie Ballantyne has been recognized with several awards. These include the Distinguished Fellowship Award from the American College of Cardiology (2013), Fellowship of the American Association for the Advancement of Science (2004), and membership in the Association of American Physicians.

Best Publications

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    Paul M Ridker;Brendan M. Everett;Tom Thuren;Jean G. MacFadyen

  • From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

    Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells;S. Ward Casscells

  • Biological, clinical and population relevance of 95 loci for blood lipids

    Tanya M. Teslovich;Kiran Musunuru;Albert V. Smith;Andrew C. Edmondson

  • Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

    Steven E. Nissen;Stephen J. Nicholls;Ilke Sipahi;Peter Libby

  • Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

    Deepak L. Bhatt;P. Gabriel Steg;Michael Miller;Eliot A. Brinton

  • Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association

    Michael Miller;Neil J. Stone;Christie Ballantyne;Vera Bittner

  • Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

    Gregory G. Schwartz;Anders G. Olsson;Markus Abt;Christie M. Ballantyne

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study

    Ann Marie McNeill;Wayne D. Rosamond;Cynthia J. Girman;Cynthia J. Girman;Sherita Hill Golden

  • Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.

    Bruce B. Duncan;Bruce B. Duncan;Maria Inês Schmidt;Maria Inês Schmidt;James S. Pankow;Christie M. Ballantyne

  • Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

    Stephen J. Nicholls;Christie M. Ballantyne;Philip J. Barter;M. John Chapman

  • Carotid Intima-Media Thickness and Presence or Absence of Plaque Improves Prediction of Coronary Heart Disease Risk: The ARIC (Atherosclerosis Risk In Communities) Study

    Vijay Nambi;Vijay Nambi;Lloyd Chambless;Aaron R. Folsom;Max He

  • Criteria for Evaluation of Novel Markers of Cardiovascular Risk A Scientific Statement From the American Heart Association

    Mark A. Hlatky;Philip Greenland;Donna K. Arnett;Christie M. Ballantyne

  • Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

    Stephen J. Nicholls;Stephen J. Nicholls;Rishi Puri;Todd Anderson;Christie M. Ballantyne

  • Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study

    Christie M. Ballantyne;Ron C. Hoogeveen;Heejung Bang;Josef Coresh

  • Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia: A Prospective, Randomized, Double-Blind Trial

    Christie M. Ballantyne;John Houri;Alberto Notarbartolo;Lorenzo Melani

  • Loss-of-function mutations in APOC3, triglycerides, and coronary disease

    Jacy Crosby;Gina M. Peloso;Gina M. Peloso;Paul L. Auer;David R. Crosslin

  • Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

    Paul M Ridker;Jean G MacFadyen;Brendan M Everett;Peter Libby

  • A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia

    Dirk J. Blom;Tomas Hala;Michael Bolognese;Michael J. Lillestol

  • Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis

    Steven E. Nissen;Stephen J. Nicholls;Ilke Sipahi;Peter Libby

Frequent Co-Authors

Salim S. Virani
Salim S. Virani Baylor College of Medicine
Eric Boerwinkle
Eric Boerwinkle The University of Texas Health Science Center at Houston
Elizabeth Selvin
Elizabeth Selvin Johns Hopkins University
Josef Coresh
Josef Coresh New York University
Aaron R. Folsom
Aaron R. Folsom University of Minnesota
Kunihiro Matsushita
Kunihiro Matsushita Johns Hopkins University
Stephen J. Nicholls
Stephen J. Nicholls Monash University
Gerardo Heiss
Gerardo Heiss University of North Carolina at Chapel Hill
James S. Pankow
James S. Pankow University of Minnesota
Harold E. Bays
Harold E. Bays Louisville Metabolic and Atherosclerosis Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens many doors beyond traditional medical degrees. Online health care education is becoming increasingly popular, offering flexibility and career advancement options for busy professionals and recent graduates alike.

Those looking to advance in healthcare management can explore cahme accredited online mha programs. These programs ensure rigorous, industry-recognized training for future administrators and leaders in healthcare settings.

For nurses, there are streamlined pathways for academic progress. If you are a registered nurse seeking bachelor's credentials, you can consider online rn-bsn programs without clinicals, which are ideal for those who need to balance work and study without additional clinical requirements.

Looking to fast-track a doctorate? Prospective nurse leaders might be interested in a 1 year dnp program online for accelerated learning, or select from the easiest online dnp programs to advance clinical and organizational skills with manageable coursework.

These online options help medical and healthcare professionals upskill efficiently while meeting changing industry needs.

Best Scientists Citing Christie M. Ballantyne

Trending Scientists

Recently Published Articles